Advanced search
Publication Cover
Cancer Investigation Volume 38, 2020 - Issue 4
Submit an article Journal homepage
53
Views
0
CrossRef citations to date
0
Altmetric
Articles

Distribution of Femoral Metastases; Potential Role for Extended FDG PET/CT Scanning

Ghada IssaRadiology and Nuclear Medicine, University of Maryland Medical School, Baltimore, Maryland, USA
,
Sonya KhanRadiology and Nuclear Medicine, University of Maryland Medical School, Baltimore, Maryland, USA
&
Michael MulliganRadiology and Nuclear Medicine, University of Maryland Medical School, Baltimore, Maryland, USACorrespondence[email protected]
Pages 250-256 | Received 17 Jan 2020, Accepted 23 Feb 2020, Published online: 05 Mar 2020

References

  • Saad F, Lipton A, Cook R, Chen YM, Smith M, Coleman R. Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer. 2007;110(8):1860–1867. doi:10.1002/cncr.22991.
  • Macedo F, Ladeira K, Pinho F, Saraiva N, Bonito N, Pinto L, Gonçalves F. Bone metastases: an overview. Oncol Rev. 2017;11(1):321. doi:10.4081/oncol.2017.321.
  • Jonas S, Mehendale S, Bick S, Baker R. Current orthopaedic management of bony metastases in the proximal third of the femur. Hip Int. 2017;27(1):1–7. doi:10.5301/hipint.5000497.
  • Chang-Young S, Sung-Taek J. Metastatic pathologic fractures in lower extremities treated with the locking plate. J Korean Bone Joint Tumor Soc. 2010;16:80–86. doi:10.5292/jkbjts.2010.16.2.80.
  • Yu Z, Xiong Y, Shi R, Min L, Zhang W, Liu H, et al. Surgical management of metastatic lesions of the proximal femur with pathological fractures using intramedullary nailing or endoprosthetic replacement. Mol Clin Onc. 2018;8:107–114. doi:10.3892/mco.2017.1503.
  • Yazawa Y, Frassica FJ, Chao EY, Pritchard DJ, Sim FH, Shives TC. Metastatic bone disease. A study of the surgical treatment of 166 pathologic humeral and femoral fractures. Clin Orthop Relat Res. 1990;251:213–219.
  • Habermann ET, Sachs R, Stern RE, Hirsh DM, Anderson WJ. Jr. The pathology and treatment of metastatic disease of the femur. Clin Orthop Relat Res. 1982;169:70–82.
  • Sebro R, Mari-Aparici C, Hernandez-Pampaloni M. Value of true whole-body FDG-PET/CT scanning protocol in oncology: optimization of its use based on primary diagnosis. Acta Radiol. 2013;54(5):534–539. doi:10.1177/0284185113476021.
  • Lazaga FJ, Oz OK, Adams-Huet B, Anderson J, Mathews D. Comparison of whole-body versus limited whole-body 18F-FDG PET/CT scan in malignant cutaneous melanoma. Clin Nucl Med. 2013;38(11):882–884. doi:10.1097/RLU.0b013e3182a77cae.
  • Kawata S, Imaizumi M, Kako Y, Oku N. Clinical impact of “true whole-body” (18)F-FDG PET/CT: lesion frequency and added benefit in distal lower extremities. Ann Nucl Med. 2014;28(4):322–328. doi:10.1007/s12149-014-0814-0.
  • Querellou S, Keromnes N, Abgral R, Sassolas B, Le Roux PY, Cavarec MB, et al. Clinical and therapeutic impact of 18F-FDG PET/CT whole-body acquisition including lower limbs in patients with malignant melanoma. Nucl Med Commun. 2010;31(9):766–772. doi:10.1097/MNM.0b013e32833cb8b7.
  • Selvaggi G, Scagliotti GV. Management of bone metastases in cancer: a review. Crit Rev Oncol Hematol. 2005;56(3):365–378. doi:10.1016/j.critrevonc.2005.03.011.
  • Dijkstra P. Pathological fractures of long bones due to bone metastases [thesis]. [Rotterdam (Netherlands)]; 1997. ISBN 90-9011034-8
  • Chau S, Chandra M, Grimsrud C, Gonzalez J, Hui R, Lo J. Femur fracture classification in women with a history of breast cancer. J Bone Oncol. 2014;3(2):49–53. doi:10.1016/j.jbo.2014.03.002.
  • Ormsby N, Leong W, Wong W, Hughes H, Swaminathan V. The current status of prophylactic femoral intramedullary nailing for metastatic cancer. ecancer. 2016;10:698. doi:10.3332/ecancer.2016.698.
  • Osman M, Chaar B, Muzaffar R, Oliver D, Reimers H, Walz B, Nguyen N. 18F-FDG PET/CT of patients with cancer: comparison of whole-body and limited whole-body technique. Am J Roentgenol. 2010;195(6):1397–1403. doi:10.2214/AJR.09.3731.
  • Nikkel L, Mahmood B, Lander S, Maceroli M, Fox E, Tyler W, et al. Hospitalizations for fracture in patients with metastatic disease: primary source lesions in the United States. JCSO. 2018;16:e14–e20. doi:10.12788/jcso.0385.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.